These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 21331912)
1. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664 [TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of immunotoxins in the treatment of HIV-infected humans. Van Oijen MG; Preijers FW J Drug Target; 1998; 5(2):75-91. PubMed ID: 9588864 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon. Muñoz A; Carrasco L; Fresno M J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939 [TBL] [Abstract][Full Text] [Related]
5. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Hsueh FW; Walker CM; Blackbourn DJ; Levy JA Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759 [TBL] [Abstract][Full Text] [Related]
6. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
7. Engineered virus targets HIV-infected cells: interview with Garry Nolan, Ph.D. Interview by John S. James. Nolan G AIDS Treat News; 1997 Sep; (No 279):1, 3-5. PubMed ID: 11364688 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy. Yang QE Med Hypotheses; 2004; 62(3):358-63. PubMed ID: 14975503 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Popik W; Pitha PM Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218 [TBL] [Abstract][Full Text] [Related]
10. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms. Korth MJ; Taylor MD; Katze MG Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919 [TBL] [Abstract][Full Text] [Related]
11. Conversion of trichosanthin-induced CD95 (Fas) type I into type II apoptotic signaling during Herpes simplex virus infection. He D; Yau K; He X; Shi H; Zheng Y; Tam S Mol Immunol; 2011 Sep; 48(15-16):2000-8. PubMed ID: 21723610 [TBL] [Abstract][Full Text] [Related]
12. [How the bovine viral diarrhea virus outwits the immune system]. Peterhans E; Jungi TW; Schweizer M Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):124-9. PubMed ID: 16716045 [TBL] [Abstract][Full Text] [Related]
13. Effects of the exogenous Nef protein on HIV-1 target cells. Pugliese A; Cantamessa C; Saini A; Piragino A; Gennero L; Martini C; Torre D Cell Biochem Funct; 1999 Sep; 17(3):183-92. PubMed ID: 10451539 [TBL] [Abstract][Full Text] [Related]
14. Adenine-induced selective apoptosis toward HIV chronically infected cells in vitro. Hirasawa K; Yoshida O; Fujinami T; Sohma K; Watanabe A Biochem Biophys Res Commun; 2000 Jul; 273(3):1025-32. PubMed ID: 10891366 [TBL] [Abstract][Full Text] [Related]
15. Antiviral, cytotoxic and apoptotic activities of picolinic acid on human immunodeficiency virus-1 and human herpes simplex virus-2 infected cells. Fernandez-Pol JA; Klos DJ; Hamilton PD Anticancer Res; 2001; 21(6A):3773-6. PubMed ID: 11911246 [TBL] [Abstract][Full Text] [Related]